Effect of Pantoprazole on the Absorption of Hydroxychloroquinea A Randomized Drug‐Drug Interaction Trial in Healthy Adults-Reference-Cited by-同舟云学术

Effect of Pantoprazole on the Absorption of Hydroxychloroquinea A Randomized Drug‐Drug Interaction Trial in Healthy Adults

Published:2021-07-15 Issue:2 Volume:11 Page:285-290
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:Clinical Pharm in Drug Dev

Author:

Stoll Felicitas¹,Blank Antje¹,Mikus Gerd¹,Czock David¹,Foerster Kathrin I.¹,Hermann Simon¹,Gümüs Katja¹,Muhareb Amin¹,Hummler Simone¹,Sauter Max¹,Weiss Johanna¹,Burhenne Jürgen¹,Haefeli Walter E.¹

Affiliation:

1. Department of Clinical Pharmacology and Pharmacoepidemiology Heidelberg University Hospital Heidelberg Germany

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpdd.999

Reference21 articles.

1. Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

2. Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus

3. Pharmacokinetics and pharmacodynamics of hydroxychloroquine enantiomers in patients with rheumatoid arthritis receiving multiple doses of racemate

4. Hydroxychloroquine Blood Levels Predict Hydroxychloroquine Retinopathy

5. Pharmacokinetics and Pharmacological Properties of Chloroquine and Hydroxychloroquine in the Context of COVID‐19 Infection

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hydroxychloroquine: Pharmacokinetics and Toxicity;Journal of Clinical Pharmacy and Therapeutics;2024-01-24

2. Evaluation of Hydroxychloroquine as a Perpetrator on Cytochrome P450 (CYP) 3A and CYP2D6 Activity with Microdosed Probe Drugs in Healthy Volunteers;European Journal of Drug Metabolism and Pharmacokinetics;2023-12-20

3. An update on drug–drug interactions associated with proton pump inhibitors;Expert Opinion on Drug Metabolism & Toxicology;2022-05-04